Overexpression of the new mutants resulted in ligand-independent hyperphosphorylation of the receptor, suggesting this is a general feature of VMCM-causative TIE2 mutations.
C1838437
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL